niaaa: current priorities and future goals · niaaa extramural grant portfolio, fy 2014 . total...
TRANSCRIPT
NIAAA: Current Priorities and Future Goals
George F. Koob, Ph.D.Director
National Institute on Alcohol Abuse and AlcoholismNational Institutes of Health
Friends of NIAAA Annual MeetingMay 12, 2015
2014:• Courtesy visits with members of Congress• Congressional briefing on new horizons in treatment of
alcohol use disorder• Joint Congressional briefing on the impact of substance use
on adolescent brain development
2015:• Congressional briefing on Fetal Alcohol Spectrum Disorders
Thank you for supporting and promoting NIAAA’s mission and work.
Cost and Scope of Addiction
1.1
13
30.5
16.6
0 20 40
HIV/AIDS
Cancer
Drug & Tobacco
Alcohol
Millions in the USPrevalence
36
202
316
223
0 200 400
HIV/AIDS
Cancer
Drug & Tobacco
Alcohol
Billions of dollarsCost to society
Alcohol Effects Across the Lifespan
NIAAA supports research to study how alcohol can affect health and well-being at various stages of life.
Alcohol
PrenatalAlcohol
Exposure
Underage / BingeDrinking Organ
Damage
MedicationInteractions
Alcohol Use Disorder
AlcoholicFamily
Environment
Lifespan Transcending Themes:• Neurobiology• Metabolism• Genetics • Epigenetics • Epidemiology• Health Services Research
NIAAA Extramural Grant Portfolio, FY 2014 Total Funding $330M, 960 projects
• International Research• Mechanisms of
Behavior Change• Underage Drinking
NIAAA Trans-Divisional Research Emphasis Areas• Biomarkers• Fetal Alcohol Spectrum
Disorders• Genes and Environment
• Health Disparities• HIV and AIDS• Systems Biology• Medications Development
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
Fetal Alcohol Spectrum Disorders (FASD) Facial Features Correlate with CNS Deficits
Negative correlations between brain volume and lipometer scores after controlling for scan location, age, sex, and ICV in subjects with FASD. (N=52)
Roussotte, F. F., Sulik, K., Mattson, S. N., Riley, E. P., Jones, K. L., Adnams, C.,et al. Human Brain Mapping, 33(2012) 920-37
LipometerScore
With permission Lebel & Sowell
Progress in Fetal Alcohol Spectrum Disorders
• Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD)• A multidisciplinary consortium of domestic and international projects focused on
FASD prevention, diagnosis, and intervention.
• CIFASD researchers have developed 3D photography and imaging techniques to enhance the detection of a broad range of facial changes caused by prenatal alcohol exposure in children who have cognitive impairments but lack the hallmark facial features associated with FAS.
• Software is being developed to enable use of hand-held cameras to acquire images.
• Improved identification of prenatal alcohol exposure could lead to earlier intervention and improved treatment outcomes for affected children.
• Collaboration on FASD Prevalence (CoFASP)• A research consortium focused on establishing a more precise and representative
prevalence estimate of FASD among school-aged children in several U.S. communities in California, North Carolina, and the Northern Plains, using active case ascertainment methodology.
• A recent study has estimated the prevalence of FAS in a representative U.S. Midwestern community in the U.S. to be higher than older, previously accepted estimates generated from less representative samples that did not use case ascertainment (6-9 cases/1,000 vs. 2 cases/1,000).
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
National Consortium on Alcohol and Neurodevelopment in Adolescence
(N-CANDA)
• Multisite longitudinal study of more than 800 youth ages 12-21 using advanced brain images and other tools
• Objectives:– To elucidate the short- and long-tem effects of alcohol exposure
on the developing brain– To identify brain structural and functional anomalies that result
from alcohol exposure as well as predict onset of AUD and otherpsychopathology
• N-CANDA has generated a number of recent research findings including evidence that youth who drink heavily show structural abnormalities in the frontal cortex of the brain
• N-CANDA’s success demonstrates that the much larger Alcohol Brain Cognitive Development (ABCD) Study can be done successfully
NCANDA Data Pipeline and AnalysisClinical, Neuroimaging, and Neuropsychological Assessment
Sex Differences
Tota
l G
ray
Mat
ter
Volu
me
AgeSex Similarities
Tota
l Cor
tical
Th
ickn
ess
Age
Neuropsychological Testing• 8 functional domains
• 25 tests• >1000 measures
AgeAge
Stroop testing "on land" (N=621)
Stroop testing in the scanner (N=268)
e.g., Stroop Match-to-Sample• response inhibition
• bottom-up top-down control
Sample as of September 2014Baseline 7881 year follow-up 303
Age
>1000 clinical and descriptive measures
Harmonize Measurement across Sites
Age
Frac
tiona
l Ani
sotr
opy
(FA
)Fr
actio
nal A
niso
trop
y (F
A)
Correction factor applied to reduce scanner variance
Structural MRI
Diffusion Tensor Imaging (DTI)
Resting-state functional MRI
Adolescent Brain Cognitive Development (ABCD) Study
• Collaborative effort of NIH ICs through the Collaborative Research on Addiction at NIH (CRAN) initiative
• Multisite longitudinal study of 10,000 adolescents who will be recruited prior to the initiation of substance use and followed over 10 years
• Will assess the short- and long-term effects of alcohol and other substance misuse, alone and in combination, on adolescent brain and cognitive development, functional outcomes and individual trajectories
• 3 FOAs issued in February 2015 for an overall coordinating center, research project sites, and a central data analysis center; applications will be reviewed in summer 2015
College Alcohol Interventions Matrix (CollegeAIM)
• Binge drinking and high intensity drinking remain a significant problem among college students.
• In response to a request from NIAAA’s College Presidents Working Group, NIAAA engaged top researchers in the field to develop an interactive, user-friendly “decision support system” to help colleges and universities select appropriate strategies to meet their alcohol intervention goals.
• This decision tool, the College AIM, will allow users to search for strategies according to intervention level (e.g., individual, group, campus-wide, community) and evaluate factors such as effectiveness, cost, and ease of implementation
• CollegeAIM is being finalized and is scheduled for release in September 2015 with participation from the NIAAA College President’s Working Group (current membership – 13 presidents)
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
NIAAA Medications Development ProgramNIAAA Clinical Investigations Group (NCIG) streamlines the medications development process by bridging the gap betweenpreclinical studies and expensive, time-consuming Phase 3 trials. NCIG:
• facilitates quick turnaround on studies (1½ years)• has access to many CNS compounds through collaborations
with the pharmaceutical industry
• recently completed a trial of a vasopressin antagonist
• in May 2015 will be launching a clinical trial of the widely prescribed anticonvulsant gabapentin
NIAAA’s intramural program also conducts clinical studies on novel compounds with AUD treatment potential.
NIAAA also focuses on disseminating information about treatment options to health professionals and the general public.
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
Co-morbidities: Alcohol Use Disorder and Post-traumatic Stress Disorder
• The severe adjustment problems often associated with exposure to trauma have drawn attention to the frequent and problematic co-morbidity of alcohol misuse and post-traumatic stress disorder (PTSD).
• This is particularly noted in military personnel associated with the wars in Iraq and Afghanistan. 10-20% of these military personnel meet criteria for PTSD and ~ 30% of this group meet criteria for alcohol misuse.
• NIAAA is seeking to better understand the relationship between AUD and PTSD, and to develop interventions to prevent and treat these disorders.
• For example, NIAAA will be expanding research on the neurobiological mechanisms that underlie co-occurring PTSD and AUD, e.g. the brain’s stress systems, and exploring collaborative opportunities.
• NIAAA sponsored a basic research symposium on the topic at the Society for Neuroscience meeting in 2014 and will be sponsoring a clinically focused session at the 2015 American College on Neuropsychopharmacology.
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
NIAAA is Addressing Alcoholic Liver Disease
• In 2013, of the 71,713 total liver disease deaths among individuals aged 12 and older, 46.4% involved alcohol.
• Among all cirrhosis deaths in 2011, 48.0% were alcohol related.
• The proportion of alcohol-related cirrhosis was highest (72.7%) among decedents ages 25–34, followed by decedents aged 35–44, at 70.3%.
• In 2009, alcohol-related liver disease (ALD) was the primary cause of almost 1 in 3 liver transplants in the United States.
• NIAAA supports basic and translational research on the pathogenesis of ALD and is exploring novel therapeutic targets for ALD treatment.
• NIAAA supports four alcoholic hepatitis (AH) research consortia that are collaborating to expedite the translation of basic research into improved treatments for AH.
Building a New Research Program for Alcoholic Hepatitis
David W CrabbNaga P Chalasani
Arun J SanyalVijay H Shah
Translational Research and Evolving Alcoholic Hepatitis
Treatment (TREAT)
Ramon BatallerPhilippe Mathurin
Bernd SchnablDavid Brenner
Robert SchwabeWajahat Mehal
InTeam Consortium
Timothy R MorganZhang-Xu Liu
Samuel W FrenchChad P GarnerDavid G Camp
Southern California Alcoholic Hepatitis Consortium
Gyongyi SzaboArthur McCullough
Mack MitchellLaura E Nagy
Craig J McClain
Defeat Alcoholic SteatoHepatitis
(DASH)FY12
FY13
ALCOHOL
systemic metabolic disorders
metabolic liver disorders
Lipopolysaccharides (LPS)[Endotoxemia]
Cytokines: IL8, IL1, IL6TNFα
Gut permeability
Kupffer cell activation
(Modified from Haber et al. 2002)
Malnutrition
Impaired DNA synthesis and
dysregulation ofcell signalling
Dietary Imbalance
STATs
Stellate cell activation
Toxic alcohol metabolites
NADH:NAD
ADHCYP2E1
Acetaldehyde
Adducts
Oxidative Stress
Multi-Factorial Pathogenesis of ALD
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
NIAAA Research on Alcohol and HIV/AIDS
• Alcohol misuse contributes to the spread of HIV/AIDS world-wide.
• Alcohol misuse also affects HIV/AIDS treatment, e.g. by affecting medication adherence.
• NIAAA supports research in the U.S. and globally to:
– Characterize the role of alcohol misuse in the acquisition, transmission, and progression of HIV
– Translate research findings into effective, culturally appropriate interventions
• NIAAA is working collaboratively with the NIH Office of AIDS Research on these important issues.
Key NIAAA Initiatives and Programs
1. Fetal Alcohol Spectrum Disorders – Prevention & Early Diagnosis
2. Underage and Binge Drinking – N-CANDA, ABCD, CollegeAIM
3. Treatment – Medications Development
4. Co-Morbidities – PTSD
5. Alcoholic Liver Disease
6. Alcohol and HIV/AIDS
7. Alcohol Biosensors
NIAAA Alcohol Biosensor Program• Wearable, continuous alcohol monitoring devices are
commonly used in criminal justice and other settings.• Continuous alcohol monitoring is also important for individuals
with ALD or other medical conditions exacerbated by alcohol, e.g. HIV/AIDS and Hepatitis C.
• NIAAA issued a public challenge to stimulate design and production of a non-invasive, wearable device to monitor blood alcohol levels in real time.
• The device should be inconspicuous, low profile, and appealing to the wearer. The design can take the form of jewelry, clothing, or any other format located in contact with the human body.
• The challenge will close in December 2015 and winners will be announced in February 2016.
• Prizes: $200,000 (1st place), $100,000 (2nd place)• NIAAA also supports an alcohol biosensor SBIR/STTR initiative.
NIAAA Alcohol Biosensor Challenge
NIAAA: The Source for Credible Science Information on Alcohol Across the Lifespan
Where We Want to Be1. FDA approval for medications for treatment of alcohol use
disorder (AUD)2. Implementation of effective behavioral treatments for AUD3. Implementation of effective prevention strategies for
adolescent drinking4. Implementation of effective prevention strategies for drinking
during pregnancy5. Elimination of alcohol-related HIV pathology6. Establishment of effective treatments for fetal alcohol
spectrum disorders (FASD)7. Development of effective treatments for alcoholic liver disease8. Appropriate treatment of co-morbidities associated with AUD9. Successful recruitment of young investigators to the alcohol
field; elimination of disparities in the alcohol field; equal pay for women and minorities in the alcohol field
George F. Koob, Ph.D.Director
National Institute on Alcohol Abuse and AlcoholismNational Institutes of Health
Thank You!